From: Protective effects of Alamandine against doxorubicin-induced liver injury in rats
Groups | Control (Group I) | Sham (Group II) | DOX (Group III) | Alamandine (Group IV) | Alamandine + DOX (Group V) |
---|---|---|---|---|---|
ALT (SGPT), U/L | 79.87 ± 7.73 | 85.70 ± 8.10 | 286 ± 68.79* | 84.27 ± 35.40 | 109.14 ± 12.17** |
AST (SGOT), U/L | 110.14 ± 5.40 | 113.11 ± 5.32 | 235.12 ± 21.32* | 108.28 ± 4.60 | 137.36 ± 6.72** |
ALP, U/L | 203 ± 2.78 | 183 ± 5.85 | 290 ± 5.61* | 189 ± 5.32 | 198.6 ± 8.25** |